Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer.
Formenti SC, Spicer D, Skinner K, Cohen D, Groshen S, Bettini A, Naritoku W, Press M, Salonga D, Tsao-Wei D, Danenberg K, Danenberg P. Formenti SC, et al. Among authors: groshen s. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):397-405. doi: 10.1016/s0360-3016(01)02655-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872285
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.
Formenti SC, Volm M, Skinner KA, Spicer D, Cohen D, Perez E, Bettini AC, Groshen S, Gee C, Florentine B, Press M, Danenberg P, Muggia F. Formenti SC, et al. Among authors: groshen s. J Clin Oncol. 2003 Mar 1;21(5):864-70. doi: 10.1200/JCO.2003.06.132. J Clin Oncol. 2003. PMID: 12610186 Clinical Trial.
Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy.
Formenti SC, Dunnington G, Uzieli B, Lenz H, Keren-Rosenberg S, Silberman H, Spicer D, Denk M, Leichman G, Groshen S, Watkins K, Muggia F, Florentine B, Press M, Danenberg K, Danenberg P. Formenti SC, et al. Among authors: groshen s. Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1059-68. doi: 10.1016/s0360-3016(97)00506-3. Int J Radiat Oncol Biol Phys. 1997. PMID: 9392545
P7 antigen expression in human breast cancer.
Yang X, Groshen S, Formenti SC, Davidson NE, Press MF. Yang X, et al. Among authors: groshen s. Clin Cancer Res. 2003 Jan;9(1):201-6. Clin Cancer Res. 2003. PMID: 12538470
Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV. Schneider S, et al. Among authors: groshen s. J Am Coll Surg. 2005 Mar;200(3):336-44. doi: 10.1016/j.jamcollsurg.2004.10.035. J Am Coll Surg. 2005. PMID: 15737843
MDR1 gene expression in primary and advanced breast cancer.
Yang X, Uziely B, Groshen S, Lukas J, Israel V, Russell C, Dunnington G, Formenti S, Muggia F, Press MF. Yang X, et al. Among authors: groshen s. Lab Invest. 1999 Mar;79(3):271-80. Lab Invest. 1999. PMID: 10092063
Salvage chemotherapy with CPT-11 for recurrent meningioma.
Chamberlain MC, Tsao-Wei DD, Groshen S. Chamberlain MC, et al. Among authors: groshen s. J Neurooncol. 2006 Jul;78(3):271-6. doi: 10.1007/s11060-005-9093-x. Epub 2006 Apr 21. J Neurooncol. 2006. PMID: 16628476 Clinical Trial.
398 results